![](/img/cover-not-exists.png)
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma
Chakrabarti, Sakti, Zemla, Tyler J., Ahn, Daniel H., Ou, Fang‐Shu, Fruth, Briant, Borad, Mitesh J., Hartgers, Mindy L., Wessling, Jaclynn, Walkes, Rachel L., Alberts, Steven R., McWilliams, Robert R.,Journal:
The Oncologist
DOI:
10.1634/theoncologist.2019-0874
Date:
December, 2019
File:
PDF, 689 KB
2019